About
Cell Therapies
Areas of Focus
Categories
Stem Cell & Cellular TherapyChina
Team (4)
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
9
As Collaborator
0
Total Enrollment
524
By Phase
PHASE1: 6PHASE2: 1EARLY_PHASE1: 1PHASE1/PHASE2: 1
By Status
RECRUITING: 4UNKNOWN: 2COMPLETED: 1TERMINATED: 1SUSPENDED: 1
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06515314Lead Sponsor
HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid Tumors
PHASE1Recruiting
12 participants
Started: Aug 10, 2024 · Completed: Aug 10, 2027
NCT06277154Lead Sponsor
MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue Sarcoma
PHASE2Recruiting
148 participants
Started: Feb 21, 2024 · Completed: Feb 28, 2027
NCT05952947Lead Sponsor
HRYZ-T101 Injection for HPV18 Positive Solid Tumor
PHASE1Recruiting
32 participants
Started: Nov 1, 2023 · Completed: Feb 29, 2028
NCT05787535Lead Sponsor
HRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
PHASE1Unknown
17 participants
Started: Mar 21, 2023 · Completed: Sep 30, 2025
NCT05877651Lead Sponsor
MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.
PHASE1Completed
22 participants
Started: Apr 21, 2020 · Completed: Oct 15, 2021
Locations (1)
Headquarters
Guangzhou, China
Map
Loading map...